High-dose nedocromil sodium as an addition to inhaled corticosteroids in the treatment of asthma (Q72837610)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7972972%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

title

High-dose nedocromil sodium as an addition to inhaled corticosteroids in the treatment of asthma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7972972%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

1 reference

S P O'Hickey

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7972972%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

P J Rees

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7972972%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

publication date

1 August 1994

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7972972%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7972972%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

volume

88

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7972972%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7972972%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

page(s)

499-502

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7972972%20AND%20SRC:MED&resulttype=core&format=json

A comparison of inhaled beclomethasone dipropionate and nedocromil sodium as additional therapy in asthma

29 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2805%2980330-0

7 January 2021

Effectiveness of nedocromil sodium versus placebo as additions to routine asthma maintenance therapy: a multicentre, double-blind, group comparative trial

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2805%2980330-0

7 January 2021

Nedocromil sodium in adults with asthma dependent on inhaled corticosteroids: a double blind, placebo controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2805%2980330-0

7 January 2021

Effects of adding nedocromil sodium (Tilade) to the routine therapy of patients with bronchial asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2805%2980330-0

7 January 2021

A 3-month evaluation of the efficacy of nedocromil sodium in asthma: a randomized, double-blind, placebo-controlled trial of nedocromil sodium conducted by a Canadian multicenter study group

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2805%2980330-0

7 January 2021

Purpura and dermal thinning associated with high dose inhaled corticosteroids

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2805%2980330-0

7 January 2021

Bone turnover during high dose inhaled corticosteroid treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2805%2980330-0

7 January 2021

Damage of the airway epithelium and bronchial reactivity in patients with asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2805%2980330-0

7 January 2021

Regular inhaled beta-agonist treatment in bronchial asthma.

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2805%2980330-0

7 January 2021

The use of beta-agonists and the risk of death and near death from asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2805%2980330-0

7 January 2021

10.1016/S0954-6111(05)80330-0

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7972972%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

1 reference